OMNIPAQUE 240MG/mL 50mL VL 10BX

OMNIPAQUE 240 (Iohexol 240mg/mL), supplied in 50mL vials (10-pack), is a non-ionic, iodine-based contrast media used to enhance visualization during diagnostic imaging procedures. Manufactured by GE Healthcare, this injectable solution is designed for intravascular or body cavity administration in a variety of applications, including CT scans, angiography, and general radiography of the head, abdomen, urinary tract, and reproductive system (e.g., hysterosalpingography). Its non-ionic formulation offers a lower risk of adverse reactions compared to older high-osmolar contrast agents, providing sharp contrast and supporting accurate diagnosis and treatment planning. OMNIPAQUE 240 is widely used in both human and veterinary imaging settings, but it must be administered with caution in patients with a history of iodine sensitivity, kidney disease, dehydration, or certain endocrine conditions like pheochromocytoma. Side effects can include nausea, headache, dizziness, diarrhea, fever, or localized swelling, while rare but serious complications such as seizures, cardiac events, or coma may occur in at-risk populations. Special consideration is needed when used in combination with medications like metformin due to the potential for contrast-induced nephropathy. Proper dosing, pre- and post-procedure hydration, and monitoring are essential, particularly in pediatric, geriatric, and pregnant patients. OMNIPAQUE 240 should be stored at room temperature and used only by qualified healthcare professionals trained in imaging protocols and contrast safety.